The failure of Proposal No. 4 may relate to a specific governance or compensation matter, but the filing does not disclose its content. Monitor for any subsequent 6-K or proxy statement detailing the proposal and management's next steps.
Price Chart
Executive Summary
Nasus Pharma held its Annual and Special General Meeting of Shareholders on October 8, 2026. All agenda items were approved by the required majority except for Proposal No. 4, which failed. The filing is a routine corporate governance update with no financial data or operational impact.
Key Facts
- Annual and Special General Meeting held on October 8, 2026.
- All agenda items approved except Proposal No. 4, which was not passed.
- No financial figures, guidance, or material operational updates disclosed.
- Filing incorporated by reference into existing F-3 and S-8 registration statements.
Financial Impact
None — no financial impact disclosed.
Risk Factors
- Lack of detail on Proposal No. 4 could indicate shareholder dissent on a specific issue.
- No material financial or operational news — stock movement unlikely from this filing alone.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-046340 |
| Document: 0001493152-26-046340-index-headers.html | 0001493152-26-046340 |
| Document: 0001493152-26-046340-index.html | 0001493152-26-046340 |
| Document: 0001493152-26-046340.txt | 0001493152-26-046340 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.51 | awaiting T+20 | — | $3.49 (−0.57%) |
Sep 23, 2026 4w ago | 3 | $3.64 $3.06 | ▼ −15.93% | ▼ −16.62% | $3.49 (−4.12%) |
Sep 18, 2026 5w ago | 424B5 | $3.44 $3.21 | ▲ +6.83% | ▲ +5.92% | $3.49 (−1.45%) |
Sep 14, 2026 6w ago | 6-K | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.49 (−4.38%) |
Sep 14, 2026 6w ago | EFFECT | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.49 (−4.38%) |
Aug 21, 2026 9w ago | EFFECT | $4.00 $3.44 | ▼ −14.00% | ▼ −13.47% | $3.49 (−12.75%) |
Aug 19, 2026 9w ago | 6-K | $3.84 $3.53 | ▼ −8.07% | ▼ −6.12% | $3.49 (−9.11%) |
Aug 17, 2026 10w ago | 6-K | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.49 (−5.68%) |
Aug 17, 2026 10w ago | Press Release | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.49 (−5.68%) |
Apr 1, 2026 29w ago | EFFECT | $2.55 $2.56 | ▼ −0.39% | ▲ +9.33% | $3.49 (−36.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers